In Vitro Evaluation of a Peptide-Mesoporous Silica Nanoparticle Drug Release System against HIV-1
It has been shown that the optimized VIR-576 derivative of the natural HIV-1 entry inhibitor targeting the viral gp41 fusion peptide is safe and effective in infected individuals. However, high doses of this peptide were required, and stability, as well as delivery, must be improved for clinical app...
Main Authors: | Katharina Braun, Christina M. Stürzel, Frank Kirchhoff, Mika Lindén |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Inorganics |
Subjects: | |
Online Access: | https://www.mdpi.com/2304-6740/8/7/42 |
Similar Items
-
Mesoporous Silica Nanoparticles and Mesoporous Bioactive Glasses for Wound Management: From Skin Regeneration to Cancer Therapy
by: Sara Hooshmand, et al.
Published: (2021-06-01) -
Encapsulation and Enhanced Release of Resveratrol from Mesoporous Silica Nanoparticles for Melanoma Therapy
by: Diogo Marinheiro, et al.
Published: (2021-03-01) -
Influence of Mesoporous Silica Functionalization and Pore Size on Resveratrol Release Profiles
by: Daniel Lincu, et al.
Published: (2019-10-01) -
Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA
by: Sumita Swar, et al.
Published: (2019-09-01) -
Mesoporous Silica Nanoparticles as a System for Ciprofloxacin Drug Delivery; Kinetic of Adsorption and Releasing
by: Enas Abd Dleam, et al.
Published: (2021-06-01)